Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 7
Submit an article Journal homepage
83
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Impact of Clinical and Non-Clinical Factors on the Choice of HER2 Test for Breast Cancer

Mahima AshokWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA
,
Paul GriffinHarold and Inge Marcus Department of Industrial and Systems Engineering, Penn State University, University Park, Pennsylvania, USA
&
Michael HalpernResearch Triangle Institute (RTI) International, Washington DC, USA
Pages 735-742 | Published online: 30 Jun 2010

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

James A Lee, Megan Shaheen, Thomas Walke & Matt Daly. (2011) Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy. Expert Review of Pharmacoeconomics & Outcomes Research 11:3, pages 325-341.
Read now

Articles from other publishers (4)

QINGSONG ZHANG, FANG LIANG, YANG KE, YANPING HUO, MINGCHUANG LI, YANYAN LI & JUNMIN YUE. (2015) Overexpression of neogenin inhibits cell proliferation and induces apoptosis in human MDA-MB-231 breast carcinoma cells. Oncology Reports 34:1, pages 258-264.
Crossref
Antonio C. Wolff, M. Elizabeth H. Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, Donald C. Allred, John M.S. Bartlett, Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale & Daniel F. Hayes. (2014) Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Archives of Pathology & Laboratory Medicine 138:2, pages 241-256.
Crossref
Antonio C. WolffM. Elizabeth H. HammondDavid G. HicksMitch DowsettLisa M. McShaneKimberly H. AllisonDonald C. AllredJohn M.S. BartlettMichael BilousPatrick FitzgibbonsWedad HannaRobert B. JenkinsPamela B. ManguSoonmyung PaikEdith A. PerezMichael F. PressPatricia A. SpearsGail H. VanceGiuseppe VialeDaniel F. Hayes. (2013) Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Journal of Clinical Oncology 31:31, pages 3997-4013.
Crossref
Kathryn A. Clausen, Kimberly R. Blish, Charles E. Birse, Matthew A. Triplette, Timothy E. Kute, Gregory B. Russell, Ralph B. D’AgostinoJr.Jr., Lance D. Miller, Frank M. Torti & Suzy V. Torti. (2010) SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer. Breast Cancer Research and Treatment 129:3, pages 737-746.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.